Doctors for Drug Policy Reform (D4DPR) joined dozens of national organizations in signing a letter to Congress opposing the Combating Illicit Xylazine Act (H.R. 1266/S. 545) and the Nitazene Control Act (H.R. 5415/S. 3076).
The coalition warns that criminalizing these substances will not meaningfully reduce overdose deaths and risks repeating the failures of punitive drug policy. Instead, the letter urges Congress to prioritize health-centered, evidence-based approaches such as expanding access to medications for opioid use disorder, naloxone distribution, harm reduction services, and research on the evolving drug supply.
Read the full letter:
.svg)
